ReSS Late Breaking Science
 Call for Abstracts: April 17 - June 5, 2013 
|  |  Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation
|
Deadline Extended to August 31, 2012
Late-Breaking Abstract presentations are innovative and provide the latest breakthroughs in either basic or clinical science, presenting cutting-edge, exciting and pivotal research results. These are abstracts which describe important current research advances and which have not been submitted previously. The selection of abstracts will be based on scientific quality and novelty of research in basic or clinical science. Abstract presentations provide notable exposure and recognition for studies likely to have a significant impact on resuscitation science. Only a limited number of abstracts will be selected.
Please note that late-breaking abstracts are not a second chance for those who missed the official abstract deadline. Only state-of-the-art research with up-to-date results that has not been previously presented or published is considered a late-breaking abstract.
General Information
- The American Heart Association’s Resuscitation Science Symposium (ReSS) is a forum for presentation of novel research findings. The work covered by the abstract must not have been published (manuscript or abstract) before the date and time of presentation (Nov. 3-4, 2012).
- There is a non-refundable processing fee of US$30 for each abstract submitted.
- After the August 31, 2012, 5 p.m. CDT deadline, abstracts may not be revised in any way or resubmitted. Proofread abstracts carefully to avoid errors before submission. If accepted, your abstract will be published as submitted.
- Abstract grading is blinded and abstracts are selected on the basis of scientific merit.
- Abstract acceptance/non-acceptance status will be available in mid-September. Please ensure that the email provided is accurate as all correspondences will be sent via email.
- Accepted abstracts will be published exactly as it has been submitted in the online version of the Circulation Research: Journal of the American Heart Association.
- All accepted abstracts will be scheduled as an oral presentation on Sunday morning, November 4.
- All presentations and question-and-answer sessions will be conducted in English. Presenters may request assistance from the moderator who will repeat or rephrase questions from the audience or may ask a colleague in the audience to assist with translation.
SUBMISSION
- Abstract data may not be presented at a national or international meeting or world congress before the date and time of presentation (Nov. 3-4, 2012).
- If the abstract is submitted to more than one meeting, investigators must include new and scientifically meaningful information at the time of submission to the AHA.
- If identical abstracts are accepted for two meetings, then one must be withdrawn and AHA staff must be notified. If acceptance of a previously presented abstract is discovered prior to presentation, it will be withdrawn and acceptance of future abstracts will be jeopardized. If dual presentation of identical abstracts is discovered after presentation, the acceptance of future abstracts may be jeopardized and any award associated with the abstract will be withdrawn.
- If the accepted abstract is submitted as a paper for publication, note that rapid publication has become the norm. Investigators are responsible for coordinating simultaneous publication with other journals. If publication occurs online or in print before the time of presentation, then the abstract must be withdrawn. Please notify AHA staff by sending an email to program.participant@heart.org.
- Submission of an abstract constitutes a commitment by the author(s) to present it if accepted. Failure to present, if not justified, will jeopardize future acceptance of abstracts for the American Heart Association.
- There is no limit to the number of abstracts an investigator may submit. If selected, the presenter must be one of the co-authors listed.
Embargo Policy
Abstracts and presentations are embargoed for release at date and time of presentation or time of AHA news event. Written embargoed information cannot be shared with anyone but one-on-one embargoed media interviews can be conducted as long as the reporter agrees to abide by the embargo policy. Failure to honor embargo policies will result in the abstract being withdrawn and barred from presentation. Click here to view the complete AHA/ASA General Embargo Policies.
Preparing an Abstract
Abstract Title
An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.
Author Name(s)
- The submitting author is designated as the primary/presenting author. You may rearrange the order of the authors; however, always list the senior author last.
- If an author's name appears on more than one abstract, it must be identical on each abstract.
- Additions or deletions of author names are not permitted after August 31, 2012, 5:00 p.m. CDT
- Submit all abstracts in English.
- Authors should not "split" data to create several abstracts from one. If splitting is judged to have occurred, priority scores of related abstracts will be reduced.
- Abstracts containing identical or nearly identical data submitted from the same institution and/or individuals will be disqualified.
- Proofread abstracts carefully to avoid errors before submission. The abstract will be published exactly as it has been submitted – NO EXCEPTIONS.
Abstract Text
- Describe briefly the objectives of the study unless they are contained in the title. Include a brief statement of methods if pertinent. State findings in detail sufficient to support conclusions. Abstracts should not describe research in which the chemical identity or source of the reagent is proprietary or cannot be revealed.
- Use generic drug names.
- Do not begin sentences with numerals.
- Standard abbreviations may be used without definition. Nonstandard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
- Do not include references, credits or grant support.
- Do not include the names or personal information of any patient participating in the study or trial.
- Abstracts are limited to 1,950 characters (about 300-350 words). This includes the text plus any graphics, but not the title or authors. New this year, all figure graphics (figures) and text-based graphics (tables) should be provided as 72 dpi, pre-sized jpg images, with a maximum width of 450 pixels. Only .jpg images should be submitted. Black-and-white digital images should be in grayscale mode. Color images should be saved in RGB color mode. Addition of an image whether a figure or a table deducts 250 characters. Spaces do not count as characters.
- The format for the Circulation Research supplement allows graphics to be placed anywhere within the abstract. Do not add paragraph breaks within the body of the abstract.
Abstract Acceptance
Presentation
- Guidelines for abstract presentation will be provided to the presenting author of accepted abstracts in mid-September.
- All oral presentations must be in electronic format. Submit electronic presentations to the American Heart Association 6 hours in advance of the session start time. Instructions for presentation upload will be provided upon acceptance.
- No person may record any portion of the AHA Scientific Sessions, Scientific Conferences and ASA Stroke Conference, whether by video, still or digital photography; audio; or any other recording or reproduction mechanism. This includes recording of presentations and supporting A/V materials and of poster presentations and supporting poster materials. Additionally, science information shared by investigators at the time of a meeting is confidential and often unpublished data. Taking photos of or recording the content of meeting room slides is also prohibited, and is considered intellectual piracy and unethical. Attendees who ignore this policy will be asked to leave the educational session and are at risk of losing their badge credentials. The American Heart Association and American Stroke Association reserve the rights to all recordings or reproductions of presentations at AHA/ASA scientific conferences and meetings.
- The AHA reserves the right to all video or audio recordings of presentations at ReSS 2012.